In December of 2019, "The Law on Vaccine Administration of the People's Republic of China" requires drug regulatory administration to dispatch inspectors to stay at vaccine manufactures. This article compares the similarities and differences between domestic and foreign vaccine regulatory systems, summarizes the practical relevant experience of dispatched inspectors from Shanghai in the past three years. Then the further development and expectation of this supervisory system are discussed.